Viewing Study NCT00847834


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2025-12-27 @ 10:51 PM
Study NCT ID: NCT00847834
Status: COMPLETED
Last Update Posted: 2009-09-15
First Post: 2009-02-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese Population
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module